[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355887-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-355887-en":123},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","thermally-enhanced-efficacy-of-chemotherapy-potentiates-cisplatin-based-hyperthermic-intraperitoneal-chemotherapy-in-ovarian-cancer","Thermally enhanced efficacy of chemotherapy potentiates cisplatin-based hyperthermic intraperitoneal chemotherapy in ovarian cancer","","Ovarian cancer remains highly lethal, with frequent relapse and drug resistance. Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery and systemic chemotherapy has improved outcomes in peritoneal metastases, yet published results are inconsistent. This study tests whether HIPEC benefits stem from added chemotherapy alone or from the combination with hyperthermia in both high-grade and non-high-grade serous ovarian models, focusing on cisplatin synergy, DNA damage, apoptosis, cell cycle arrest, and survival.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/thermally-enhanced-efficacy-of-chemotherapy-potentiates-cisplatin-based-hyperthermic-intraperitoneal-chemotherapy-in-ovarian-cancer/355887/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/thermally-enhanced-efficacy-of-chemotherapy-potentiates-cisplatin-based-hyperthermic-intraperitoneal-chemotherapy-in-ovarian-cancer/355887.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"How did hyperthermia affect cisplatin’s anticancer activity?","Question",{"text":63,"@type":64},"Hyperthermia enhanced cisplatin efficacy in a temperature-dependent manner, increasing DNA damage and apoptosis and inducing G2 arrest.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},355887,1790845434,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,112,115,119],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":108,"doc_module":4,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},9,"Religion & Spirituality",20,"religion-spirituality",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":113,"show_sort_weight":110,"slug":114},"World Cup","world-cup",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":116,"slug":118},10,"Lifestyle","lifestyle",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":89,"slug":122},19,"General","general",{"code":4,"msg":74,"data":124},{"doc_id":71,"user_id":125,"nickname":42,"user_avatar":126,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThermally enhanced efficacy of chemotherapy potentiatescisplatin-based hyperthermic intraperitoneal chemotherapy in ovarian cancer  \nFan Yang1,2,3,4, Ofer Reizes5,6, H. Petra Kok2,3,4, Maarten F. Bijlsma1,3,7, Constantijne H. Mom8, Jacqueline M. Tromp8, Willemien J. van Driel9, Lukas J. A. Stalpers2,3,4, Johannes Crezee2,3,4 & Arlene L. Oei1,2,3,4􀀍  \nOvarian cancer is the deadliest gynecological malignancy, with high relapse and drug resistance rates. Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery and systemic chemotherapy has improved survival in patients with peritoneal metastases, though findings remain inconsistent. This study investigates whether the benefits of HIPEC are due to the additional chemotherapy or the combination with hyperthermia. High-grade and non-high-grade serous ovarian cancer cell lines were treated with carboplatin and paclitaxel. Additionally, the cells were treated with cisplatin at 37 to 43 °C for 90 min (HIPEC). Cell proliferation, colony formation, apoptosis, cell cycle and DNA damage were assessed by MTT, clonogenic assay, flow cytometry, western blot and γ-H2AX foci assay. High-grade serous cells were more sensitive to both carboplatin-paclitaxel and hyperthermia. Cisplatin demonstrated a temperature-dependent synergy with heat, resulting in increased DNA damage, apoptosis, and G2-arrest. Combining carboplatin and paclitaxel with hyperthermia plus cisplatin further reduced survival and increased cellular stress marker compared to carboplatin and paclitaxel alone. Hyperthermia significantly enhances cisplatin efficacy when added to carboplatin and paclitaxel pretreatment. This suggests that the addition of hyperthermia to cisplatin after carboplatinpaclitaxel is more effective than carboplatin-paclitaxel alone in both high-grade and non-high grade serous ovarian cancer.  \nKeywords Ovarian cancer, Hyperthermia, Hyperthermic intraperitoneal chemotherapy (HIPEC), Cisplatin  \nOvarian cancer is one of the most common gynecological cancers. A major challenge in treating ovarian cancer is that most patients are diagnosed at an advanced stage of the disease1. Approximately 90% of ovarian malignancies are epithelial ovarian cancers, 80% of which are high-grade serous ovarian cancer (HGSOC)2. Other histological types include low-grade serous, endometrioid, clear cell, and mucinous ovarian cancers which are called non-high-grade serous ovarian cancer (NHGSOC) . Ovarian cancer has a high recurrence rate: up to 50% for low-grade serous ovarian cancer and up to 80% for HGSOC3,4. Patients with advanced disease usually have peritoneal metastases (PM). Although the initial response to chemotherapy is good, recurrences are frequent. 80% of these recurrences are PM that are less chemo-responsive5.  \n1Laboratory of Experimental Oncology and Radiobiology (LEXOR), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. 2Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. 3Cancer Center Amsterdam, Cancer Biology and Immunology, University of Amsterdam, Amsterdam, The Netherlands. 4Cancer Center Amsterdam, Treatment and Quality of Life, University of Amsterdam, Amsterdam, The Netherlands. 5Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA. 6Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA. 7Oncode Institute, Amsterdam, The Netherlands. 8Department of Gynecologic Oncology, Amsterdam UMC, Amsterdam Medical Center, Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands. 9Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 􀀍 email: [a.l.oei@amsterdamumc.nl](a.l.oei@amsterdamumc.nl)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nMore than 75% of patients are diagnosed at","cbCaiit1baxuTtfS","https://ap.wps.com/l/cbCaiit1baxuTtfS","pdf",8026754,"English","# Background and clinical rationale\n## Ovarian cancer burden and recurrence\n## Standard treatment and role of HIPEC\n# Experimental design\n## Cell models and drug treatments\n## HIPEC conditions and assay methods\n# Key findings and mechanistic insights\n## Sensitivity differences across serous subtypes\n## Temperature-dependent cisplatin synergy with heat\n## Combination effects on survival and cellular stress","[{\"question\":\"How did hyperthermia affect cisplatin’s anticancer activity?\",\"answer\":\"Hyperthermia enhanced cisplatin efficacy in a temperature-dependent manner, increasing DNA damage and apoptosis and inducing G2 arrest.\"}]","Thermally enhanced efficacy of chemotherapy potentiates cisplatin-based hyperthermic intraperitoneal chemotherapy in ovarian cancer | PDF",1790121544,33,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec309bc3609872bc0432801506ab3a5b.webp",983,1291,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ccfd6de89a3834fdecd7b80a62568ae.webp",982,1290,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07c68f8f49a56433461904e1fc2cea0e.webp",981,1289,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5908153ce47e951292608557d8cb0300.webp",980,1287]